Use of aziridino-y-lactone methodology for the enantiospecific preparation of novel, potential therapeutic agents for the treatment of neurodegenerative diseases.

Project Information

Grant agreement ID: HPMF-CT-1999-00213

Project closed

Start date 1 March 2000

End date 28 February 2001

Funded under

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Total cost € 63 000,00

EU contribution € 63 000,00

Coordinated by

Centre National de la Recherche Scientifique (CNRS)
France

Programme(s)

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Topic(s)

Data not available

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

Centre National de la Recherche Scientifique (CNRS)

• EU contribution: No data
• Address: Avenue de la Terrasse ; 91198 Gif-sur-Yvette ; France
• Total cost: No data